BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28032719)

  • 21. Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance.
    Nishihara K; Shomori K; Tamura T; Fujioka S; Ogawa T; Ito H
    Oncol Rep; 2009 May; 21(5):1189-95. PubMed ID: 19360293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis.
    Zhong X; Chen X; Guan X; Zhang H; Ma Y; Zhang S; Wang E; Zhang L; Han Y
    Histopathology; 2015 Jan; 66(2):192-200. PubMed ID: 24805087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation.
    Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
    Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of HIF-1a, CA-IX, and OPN in T1-T2 laryngeal carcinoma treated with radiotherapy.
    Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; de Bock GH; Langendijk JA; Kluin PM; Schuuring E; van der Laan BF; van der Wal JE
    Laryngoscope; 2013 Sep; 123(9):2154-60. PubMed ID: 24167820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
    Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
    Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.
    Vassilakopoulou M; Avgeris M; Velcheti V; Kotoula V; Rampias T; Chatzopoulos K; Perisanidis C; Kontos CK; Giotakis AI; Scorilas A; Rimm D; Sasaki C; Fountzilas G; Psyrri A
    Clin Cancer Res; 2016 Feb; 22(3):704-13. PubMed ID: 26408403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T1 squamous cell carcinoma of the glottis with anterior commissure involvement: Radiotherapy versus transoral laser microsurgery.
    Alkan U; Nachalon Y; Shkedy Y; Yaniv D; Shvero J; Popovtzer A
    Head Neck; 2017 Jun; 39(6):1101-1105. PubMed ID: 28371063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma.
    Almadori G; Coli A; De Corso E; Mele DA; Settimi S; Di Cintio G; Brigato F; Scannone D; Carey TE; Paludetti G; Lauriola L; Ranelletti FO
    J Transl Med; 2021 Sep; 19(1):408. PubMed ID: 34579737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival.
    de Miguel-Luken MJ; Chaves-Conde M; Quintana B; Menoyo A; Tirado I; de Miguel-Luken V; Pachón J; Chinchón D; Suarez V; Carnero A
    Oncotarget; 2016 May; 7(22):31723-37. PubMed ID: 27166270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
    Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].
    Lévy A; Blanchard P; Janot F; Temam S; Bourhis J; Daly-Schveitzer N; Tao Y
    Cancer Radiother; 2014 Jan; 18(1):1-6. PubMed ID: 24309002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of EpCAM and prognosis in early-stage glottic cancer treated by radiotherapy.
    Murakami N; Mori T; Yoshimoto S; Ito Y; Kobayashi K; Ken H; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Sumi M; Itami J
    Laryngoscope; 2014 Nov; 124(11):E431-6. PubMed ID: 25043563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
    Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck.
    Strojan P; Grašič Kuhar C; Žumer B; Kadivec M; Karner K; Fajdiga I; Jančar B; Gale N; Poljak M; Kocjan BJ; Zakotnik B
    Head Neck; 2014 Nov; 36(11):1555-61. PubMed ID: 24123552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.
    Jarkowski A; Hare R; Loud P; Skitzki JJ; Kane JM; May KS; Zeitouni NC; Nestico J; Vona KL; Groman A; Khushalani NI
    Am J Clin Oncol; 2016 Dec; 39(6):545-548. PubMed ID: 24879468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.
    Wilkie MD; Lightbody KA; Pinto R; Tandon S; Jones TM; Lancaster J
    Clin Otolaryngol; 2015 Dec; 40(6):610-5. PubMed ID: 25816841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymph node density as an independent predictor of cancer-specific mortality in patients with lymph node-positive laryngeal squamous cell carcinoma after laryngectomy.
    Ryu IS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    Head Neck; 2015 Sep; 37(9):1319-25. PubMed ID: 24828891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.